IDIOPATHIC INFLAMMATORY MYOPATHY (IIM)
Clinical trials for IDIOPATHIC INFLAMMATORY MYOPATHY (IIM) explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC INFLAMMATORY MYOPATHY (IIM) trials appear
Sign up with your email to follow new studies for IDIOPATHIC INFLAMMATORY MYOPATHY (IIM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immune cell therapy shows promise for tough autoimmune conditions
Disease control Recruiting nowThis study tests a new treatment using specially engineered immune cells (CAR-NK) from cord blood for people with severe autoimmune diseases like lupus, scleroderma, and vasculitis that haven't improved with standard treatments. The goal is to see if a single infusion can safely …
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHY (IIM)
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 26, 2026 04:39 UTC
-
CAR t therapy takes on lupus, MS, and more in first human safety trial
Disease control Recruiting nowThis early-phase study tests a new treatment called HBI0101 CAR T for people with severe autoimmune diseases like lupus, multiple sclerosis, and rheumatoid arthritis that haven't improved with standard treatments. The therapy uses a patient's own immune cells, modified to target …
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHY (IIM)
Phase: PHASE1 • Sponsor: Polina Stepensky • Aim: Disease control
Last updated May 26, 2026 04:39 UTC
-
Experimental CAR-T therapy targets Hard-to-Treat muscle disease
Disease control Recruiting nowThis early-phase study tests a new treatment called GC012F for people with a severe muscle inflammation disease (idiopathic inflammatory myopathy) that hasn't responded to standard therapies. About 12 adults will receive an infusion of their own modified immune cells (CAR-T cells…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHY (IIM)
Phase: EARLY_PHASE1 • Sponsor: Daishi Tian • Aim: Disease control
Last updated May 26, 2026 04:32 UTC
-
New 'T cell Engager' drug tested for tough autoimmune cases
Disease control Recruiting nowThis early-phase study tests the safety of a new drug called CC312 in up to 18 adults with autoimmune diseases like lupus, arthritis, or scleroderma that haven't responded to standard treatments. CC312 works by directing the body's immune T cells to attack faulty B cells, similar…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHY (IIM)
Phase: EARLY_PHASE1 • Sponsor: CytoCares Inc • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
Blood test could end guesswork in treating arthritis and autoimmune diseases
Diagnosis Recruiting nowThis study is testing a new blood test that may help doctors choose the most effective medicine for people with rheumatic diseases like rheumatoid arthritis, lupus, and vasculitis. Researchers will take a blood sample and use it to see how a person's immune cells react to differe…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHY (IIM)
Sponsor: University of Bonn • Aim: Diagnosis
Last updated May 20, 2026 11:54 UTC